It has been shown that GSK3β increases in monocrotaline-induced PAH, and its levels are negatively modulated by HIV protease inhibitors in line with decreased proliferation in pulmonary arteries [48]. This evidence concerns the gene GSK3B and pulmonary arterial hypertension.